ONE YAHOO POSTERS VIEW Based on sales of antibiotic
ONE YAHOO POSTERS VIEW
Based on sales of antibiotic compounds and recent billion-dollar acquisitions that reflect the value of new antibiotics, we are very excited and believe that an FDA approved Brilacidin would capture a significant share of the ABSSSI market, due to its unique attributes, including short-course therapy. With ABSSSI as the lead indication, followed by other possible uses for infected wounds, bone, joint and blood stream infections, Brilacidin could fill a large void in the dwindling global portfolio of effective antibiotics. Our strategy includes capitalizing on the Generating Antibiotics Incentives Now (GAIN) Act, which, combined with other government efforts, is positively changing the regulatory climate in the developmental of drugs like Brilacidin."
....TSRX deal was worth $818M on 52.77M shares for 15.50 includes CFR fully paid out!
A CTIX comp at 117M shares currently at the 30 day MA=1.80*117=$211M in MC!
That would imply Bril could be worth 4x in future value based on the MC/ TSRX buyout by CBST if all things were equal between the two compounds which are interesting to compare but the synergy one sees w/ Tedizolid and Dificid in C.diff super infections....is quite unique and probably has much to do w/ why CBST bought TSRX..that JS sold the co. so CHEAPLEY is another question for another Time.
...I think Bril could be a $1B asset and if so and we apply a std 2x sales multiple than $2B/117M shares well U get the picture at $17/share! Lets say Im wrong and BRIL is only worth $500M/year than 2x=1B/117M shares is still ~$8.54/share!
If Im totally off base, the drug works and gets only limited INHOUSE USE for ABSSI in short course Tx than 50% of that is still 250M/year and that is imo ground floor valuation at $4/share.... if no safety issue present and efficacy is proven. So U guys tell me what B is worth range is $18-$4? If Roche partnership news is accurate than over $18 is correct imo!
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Kefir Goes Prime Time in Chicago Lifeway Foods, Inc. is stepping up its game with a splashy debut on Chicago's television scene. Just days after announcing the move, the leading player in the kefir industry is rolling out an ad campaign featuring none other than celebrated football stars Colston Loveland and D'Andre Swift. This isn't just any run-of-the-mill commercial...
Continue Reading
A Battle Cry Against Hunger Look, there’s no shortage of firms tossing around cash as PR stunts. But Duke Energy’s latest campaign to tackle hunger in South Carolina right at the root is one effort that seems to echo with a real bang. Coming at us with more than $500,000 in support for nearly 70 organizations across the state, they’re not just talking the talk. This...
Continue Reading
Sun Home's Black Friday Warm-Up If ever there was a time to crank up the heat on a deal, it’s right now. Sun Home Saunas, a San Diego stalwart in the home wellness space, launched their Black Friday blitz today, offering savings that's hotter than a summer day in Death Valley. Between November 6 and December 7, they're slashing prices left and right, tossing in free...
Continue Reading
Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...
Continue Reading
Clifford Law Offices: Winning Through Thick and Thin Well, when you hear about a law firm rubbing shoulders with the elite in the legal arena, you know they've got a story buried in cases strewn with complexity and triumph. Clifford Law Offices has etched its name in the 2027 edition of Best Law Firms®. They're not just coasting on past laurels; they're constantly...
Continue Reading
Hope in Persistence: Cesalatamig in the Spotlight Swinging through the medical landscape like a seasoned fighter, OncoC4's recent revelations at the SITC 2026 give investors and doctors a reason to pay close attention. We're sizing up their investigational drug, cesalatamig, which flaunts a solid objective response rate of 33% among non-small cell lung cancer (NSCLC)...
Continue Reading
Breakthrough in AI: Enter Q4 Nexus It's not every day you see a tech player emerge with something genuinely fresh—QORAI CORP is shaking up the scene with its Q4 Nexus platform. This isn't just another AI model upgrade. We're talking about a rethink of the very architecture we rely on to power these systems. Founder Robby Joshi's brainchild, Q4 Nexus, jazzes up the AI...
Continue Reading
Sweeping Away Construction's Admin Grit Dive headfirst into the realm of construction, and you'd think you're imitating a 20th-century manual dance—a mishmash of paper trails and stray spreadsheets. Shackleton AI is aiming to drag this business into the 21st century by ditching those clunky methods. The New York-based startup threw its hat into the tech ring with what...
Continue Reading
Revolutionizing Hospitality Design: A New Wave Some companies play it safe, sticking to tried-and-true approaches, but then there's Lagoon Furniture USA who's taking the bull by the horns with their fresh take on hospitality design ahead of BDNY 2026. Forget about following a set recipe; they're all about crafting unique identities for spaces! From Chairs to Sculptural...
Continue Reading
The Windy City Meets the Diamond Alright, bear with me here. Monday morning vibes, right? But here's something that'll turn your breakfast around if you're into baseball—or just the latest scoop on players making waves in gear. Pete Crow-Armstrong, the Chicago Cubs center fielder who's been lighting up the field, has his name on some fresh gear. We're talking signature...
Continue Reading
Top 5 Most Recently Viewed Articles
David Link Appointed to Appian Board of Directors Appian, a recognized leader in AI-powered process automation, has announced the strategic appointment of David Link to its Board of Directors, effective January 25, 2026. This move is a significant step for the company, which continues to innovate and lead in the realm of intelligent business solutions. Background of David...
Continue Reading
Understanding the Class Action for Easterly ROCMuni Fund Investors Investors of the Easterly ROCMuni High Income Municipal Bond Fund are advised to take immediate action due to significant changes affecting their investments. The Easterly ROCMuni Fund, which was previously known as the Principal Street High Income Municipal Fund (NASDAQ: RMJAX), recently faced serious...
Continue Reading
Veritas Veterinary Partners Expands Its Reach in Veterinary Care Veritas Veterinary Partners, a leading organization in specialty and emergency veterinary services, has announced its exciting expansion with two new state-of-the-art facilities. These additions represent a significant milestone for the company as they aim to provide unparalleled care for pets and support...
Continue Reading
Overview of the Commercial Aircraft Leasing Market The commercial aircraft leasing market is witnessing a robust growth trajectory, with projections indicating an increase by approximately USD 20.93 billion from 2024 to 2028. This expansion is largely driven by the rising demand for air travel and the operational needs of airlines that prefer leasing options over...
Continue Reading
Shake-Up at Red Robin: New CMO Appointed Just when you thought the restaurant industry had nothing new under the sun, Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) pulls a fast one. They're bringing Scott Hudler on board as the new chief marketing officer, right from under the noses of Whataburger. It's not exactly a small fry move. Who Is Scott Hudler? This guy has more...
Continue Reading